Salveen Richter
Stock Analyst at Goldman Sachs
(2.29)
# 2,476
Out of 4,829 analysts
213
Total ratings
38.52%
Success rate
-2.42%
Average return
Main Sectors:
Stocks Rated by Salveen Richter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FDMT 4D Molecular Therapeutics | Maintains: Buy | $51 → $44 | $3.08 | +1,328.57% | 4 | May 9, 2025 | |
| CRSP CRISPR Therapeutics AG | Maintains: Neutral | $53 → $47 | $35.62 | +31.95% | 4 | May 8, 2025 | |
| RCUS Arcus Biosciences | Maintains: Neutral | $15 → $13 | $8.28 | +57.00% | 3 | May 8, 2025 | |
| SRPT Sarepta Therapeutics | Maintains: Buy | $178 → $100 | $36.27 | +175.71% | 4 | May 7, 2025 | |
| BMRN BioMarin Pharmaceutical | Maintains: Buy | $124 → $104 | $58.86 | +76.69% | 1 | May 5, 2025 | |
| SMMT Summit Therapeutics | Maintains: Buy | $37 → $41 | $23.96 | +71.12% | 2 | May 2, 2025 | |
| FOLD Amicus Therapeutics | Maintains: Neutral | $12 → $9 | $5.99 | +50.38% | 2 | May 2, 2025 | |
| ADPT Adaptive Biotechnologies | Maintains: Buy | $9 → $10 | $9.03 | +10.74% | 11 | May 2, 2025 | |
| REGN Regeneron Pharmaceuticals | Maintains: Buy | $917 → $804 | $527.78 | +52.34% | 11 | Apr 30, 2025 | |
| BIIB Biogen | Maintains: Buy | $219 → $197 | $118.17 | +66.71% | 4 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $36 → $32 | $17.30 | +84.97% | 8 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $18 | $3.00 | +500.00% | 3 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $85 → $96 | $96.91 | -0.94% | 5 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $99 → $51 | $24.25 | +110.31% | 10 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $40 | $14.37 | +178.36% | 5 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $20 → $12 | $8.12 | +47.78% | 8 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9 → $20 | $12.79 | +56.37% | 7 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $63 → $70 | $58.98 | +18.68% | 9 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $198 → $370 | $251.15 | +47.32% | 5 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $67 → $76 | $35.11 | +116.46% | 3 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $33 → $37 | $32.30 | +14.57% | 3 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $19 → $11 | $6.57 | +67.43% | 11 | Jul 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $33 → $53 | $27.32 | +94.00% | 9 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $313 → $350 | $265.86 | +31.65% | 7 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $442 → $559 | $424.99 | +31.53% | 4 | Jan 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $5 | $4.99 | +0.20% | 4 | Sep 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4.5 → $5 | $12.30 | -59.35% | 5 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $31 | $1.16 | +2,572.41% | 7 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $257 → $225 | $287.48 | -21.73% | 1 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $22 | $1.30 | +1,592.31% | 1 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.40 | - | 4 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $30 | $5.13 | +484.80% | 5 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $14 | $0.72 | +1,840.13% | 3 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $8 → $9 | $4.33 | +107.85% | 6 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $16 → $3 | $2.13 | +40.85% | 4 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $15 → $12 | $17.44 | -31.19% | 8 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $7 → $6 | $1.82 | +229.67% | 3 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $39 → $43 | $50.47 | -14.80% | 1 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $40 → $60 | $3.50 | +1,614.29% | 6 | Aug 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $3 → $2 | $1.58 | +26.58% | 3 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $125 → $100 | $7.31 | +1,267.99% | 1 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $28 → $30 | $0.33 | +9,013.00% | 3 | Mar 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $57 → $50 | $90.66 | -44.85% | 4 | Mar 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $45 | $13.03 | +245.36% | 1 | Mar 17, 2020 |
4D Molecular Therapeutics
May 9, 2025
Maintains: Buy
Price Target: $51 → $44
Current: $3.08
Upside: +1,328.57%
CRISPR Therapeutics AG
May 8, 2025
Maintains: Neutral
Price Target: $53 → $47
Current: $35.62
Upside: +31.95%
Arcus Biosciences
May 8, 2025
Maintains: Neutral
Price Target: $15 → $13
Current: $8.28
Upside: +57.00%
Sarepta Therapeutics
May 7, 2025
Maintains: Buy
Price Target: $178 → $100
Current: $36.27
Upside: +175.71%
BioMarin Pharmaceutical
May 5, 2025
Maintains: Buy
Price Target: $124 → $104
Current: $58.86
Upside: +76.69%
Summit Therapeutics
May 2, 2025
Maintains: Buy
Price Target: $37 → $41
Current: $23.96
Upside: +71.12%
Amicus Therapeutics
May 2, 2025
Maintains: Neutral
Price Target: $12 → $9
Current: $5.99
Upside: +50.38%
Adaptive Biotechnologies
May 2, 2025
Maintains: Buy
Price Target: $9 → $10
Current: $9.03
Upside: +10.74%
Regeneron Pharmaceuticals
Apr 30, 2025
Maintains: Buy
Price Target: $917 → $804
Current: $527.78
Upside: +52.34%
Biogen
Apr 23, 2025
Maintains: Buy
Price Target: $219 → $197
Current: $118.17
Upside: +66.71%
Mar 3, 2025
Maintains: Neutral
Price Target: $36 → $32
Current: $17.30
Upside: +84.97%
Feb 27, 2025
Maintains: Buy
Price Target: $20 → $18
Current: $3.00
Upside: +500.00%
Feb 12, 2025
Maintains: Neutral
Price Target: $85 → $96
Current: $96.91
Upside: -0.94%
Jan 29, 2025
Downgrades: Neutral
Price Target: $99 → $51
Current: $24.25
Upside: +110.31%
Jan 28, 2025
Maintains: Buy
Price Target: $45 → $40
Current: $14.37
Upside: +178.36%
Jan 14, 2025
Maintains: Neutral
Price Target: $20 → $12
Current: $8.12
Upside: +47.78%
Dec 12, 2024
Maintains: Neutral
Price Target: $9 → $20
Current: $12.79
Upside: +56.37%
Oct 30, 2024
Maintains: Neutral
Price Target: $63 → $70
Current: $58.98
Upside: +18.68%
Aug 16, 2024
Upgrades: Buy
Price Target: $198 → $370
Current: $251.15
Upside: +47.32%
Aug 2, 2024
Maintains: Buy
Price Target: $67 → $76
Current: $35.11
Upside: +116.46%
Aug 2, 2024
Maintains: Sell
Price Target: $33 → $37
Current: $32.30
Upside: +14.57%
Jul 26, 2024
Maintains: Neutral
Price Target: $19 → $11
Current: $6.57
Upside: +67.43%
Jun 4, 2024
Maintains: Neutral
Price Target: $33 → $53
Current: $27.32
Upside: +94.00%
Feb 8, 2024
Maintains: Buy
Price Target: $313 → $350
Current: $265.86
Upside: +31.65%
Jan 31, 2024
Maintains: Buy
Price Target: $442 → $559
Current: $424.99
Upside: +31.53%
Sep 13, 2023
Downgrades: Neutral
Price Target: $5
Current: $4.99
Upside: +0.20%
Aug 15, 2023
Maintains: Neutral
Price Target: $4.5 → $5
Current: $12.30
Upside: -59.35%
Mar 2, 2023
Maintains: Buy
Price Target: $35 → $31
Current: $1.16
Upside: +2,572.41%
Feb 24, 2023
Maintains: Overweight
Price Target: $257 → $225
Current: $287.48
Upside: -21.73%
Nov 14, 2022
Initiates: Neutral
Price Target: $22
Current: $1.30
Upside: +1,592.31%
Nov 11, 2022
Downgrades: Neutral
Price Target: n/a
Current: $0.40
Upside: -
Nov 10, 2022
Maintains: Neutral
Price Target: $60 → $30
Current: $5.13
Upside: +484.80%
Nov 10, 2022
Maintains: Buy
Price Target: $25 → $14
Current: $0.72
Upside: +1,840.13%
Nov 9, 2022
Maintains: Neutral
Price Target: $8 → $9
Current: $4.33
Upside: +107.85%
Nov 9, 2022
Downgrades: Neutral
Price Target: $16 → $3
Current: $2.13
Upside: +40.85%
Nov 4, 2022
Downgrades: Sell
Price Target: $15 → $12
Current: $17.44
Upside: -31.19%
Nov 3, 2022
Maintains: Neutral
Price Target: $7 → $6
Current: $1.82
Upside: +229.67%
Oct 28, 2022
Maintains: Neutral
Price Target: $39 → $43
Current: $50.47
Upside: -14.80%
Aug 19, 2022
Maintains: Sell
Price Target: $40 → $60
Current: $3.50
Upside: +1,614.29%
May 24, 2022
Maintains: Sell
Price Target: $3 → $2
Current: $1.58
Upside: +26.58%
May 24, 2022
Maintains: Sell
Price Target: $125 → $100
Current: $7.31
Upside: +1,267.99%
Mar 4, 2021
Upgrades: Buy
Price Target: $28 → $30
Current: $0.33
Upside: +9,013.00%
Mar 19, 2020
Maintains: Neutral
Price Target: $57 → $50
Current: $90.66
Upside: -44.85%
Mar 17, 2020
Initiates: Neutral
Price Target: $45
Current: $13.03
Upside: +245.36%